Join VENTURE today
Invest in prostate cancer research with VENTURE and get your own pin badge, laptop sticker and more.
Invest in Research. Get the inside track.
1 in 8 men will get prostate cancer, and if you’re over 50, Black, or your dad or brother had it, you’re at an even higher risk. Prostate Cancer UK's research has already led to major breakthroughs, but by the end of the 2030s more than 1 million men will be living with or beyond the disease. And with no national screening programme for most men, research is our best chance of finding prostate cancer earlier and saving more lives. Invest in life-saving work with VENTURE and you'll receive an exclusive welcome pack with your own pin badge, laptop sticker and regular updates giving you the inside track on major projects you're helping to fund.
What you'll get
Your welcome pack when you sign up including your own Prostate Cancer UK pin badge and laptop sticker.
Regular updates direct from our researchers and men living with prostate cancer who have been helped by major advancements in science.
An exclusive impact portfolio from the forefront of game-changing research projects.
Your questions answered
TRANSFORM: Investing in the future.
Despite being the most common cancer in the UK, prostate cancer remains the only major cancer without a national screening programme. With your support, we’re funding the biggest prostate cancer screening trial in 20 years. TRANSFORM is designed to find the best way to screen men for prostate cancer, so one day, all men at risk are invited for regular tests to find aggressive cancers in time for a cure. Your investment could help get us there.
MpMRI: Yesterday's investment. Today's breakthrough.
Past investment from people like you has led to major breakthroughs in how we diagnose prostate cancer, like mpMRI. This new form of prostate imaging prevents thousands of biopsies, sparing men unnecessary pain and anxiety. Your monthly investment with VENTURE could help drive the next big advancement.
Join VENTURE today
Start donating to Prostate Cancer UK’s VENTURE and invest in men’s health.
